Science & Technology

Jeremy Ryan, a graduate student working with Meredith Jackrel in the Department of Chemistry in Arts & Sciences, won a three-year $123,090 fellowship from the National Institutes of Health (NIH).

Michael J. Krawczynski in Arts & Sciences received a three-year $178,445 grant from the National Science Foundation for a collaborative petrology and geochemistry research project.

Jonathan Barnes and Richard Loomis, both in the Department of Chemistry in Arts & Sciences, won a four-year $90,000 grant from the David and Lucile Packard Foundation for the recruitment and retention of underrepresented graduate students in chemistry’s doctoral program.

Using a novel technology, the lab of Michael Vahey at the McKelvey School of Engineering uncovered shape-shifting properties of a common respiratory virus.

Richard Loomis, professor of chemistry in Arts & Sciences, received a three-year $700,000 grant, with a collaborator at Marquette University, from the National Science Foundation to study highly energized molecules’ reaction pathways.

Washington University’s Meredith Jackrel and Jai Rudra and are researching nanofiber materials that will eliminate the need for vaccine adjuvants.

Research from the lab of Kimberly Parker at the McKelvey School of Engineering reveals key differences between single- and double-stranded RNA, insights that may prove useful to fields from agriculture to medicine.

Kevin Moeller, professor of chemistry in Arts & Sciences, won the 2021 Jaroslav Heyrovsky Prize for Molecular Electrochemistry from the International Society of Electrochemistry. His research focuses on using electrochemistry as a synthetic tool for constructing everything from complex organic molecules to two-dimensional addressable surfaces.

Using top-of-the-line research instrumentation from Agilent and Merck, scientists in the Department of Chemistry in Arts & Sciences will develop new metabolomics workflows of interest to many members of the drug-development community.

A new study with zebrafish shows that a deadly form of skin cancer — melanoma — alters the metabolism of healthy tissues elsewhere in the body. The research led by chemist Gary Patti suggests that these other tissues could potentially be targeted to help treat cancer.